DOR. (18/01/2021 - 18/01/2021)

MECANISMOS NEURAIS DA DOR. (19/01/2021 - 19/01/2021)

PRINCIPAIS CLASSES FÁRMACOS UTILIZADOS NO TRATAMENTO DA DOR. (20/01/2021 - 20/01/2021)

PRINCIPAIS MODELOS FARMACOLÓGICOS UTILIZADOS PARA AVALIAÇÃO DA ATIVIDADE ANTINOCICEPTIVA E ANTI-INFLAMATÓRIA EM ANIMAIS. (21/01/2021 - 21/01/2021)

PESQUISA, DESENVOLVIMENTO E INOVAÇÃO DE FÁRMACOS DE ORIGEM NATURAL UTILIZADOS NO TRATAMENTO DA DOR E INFLAMAÇÃO. (22/01/2021 - 22/01/2021)

SEMINÁRIOS - Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update (25/01/2021 - 25/01/2021)

SEMINÁRIOS - Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7 (26/01/2021 - 26/01/2021)

SEMINÁRIOS - Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7 (27/01/2021 - 27/01/2021)

SEMINÁRIOS - Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain (28/01/2021 - 28/01/2021)

SEMINÁRIOS - Multi-modal biomarkers of low back pain: A machine learning approach (29/01/2021 - 29/01/2021)

SEMINÁRIOS - Gastroprotective activity of kaempferol glycosides from Malvaviscus arboreus Cav. (01/02/2021 - 01/02/2021)

SEMINÁRIOS - Targeting T-type/CaV3.2 channels for chronic pain (02/02/2021 - 02/02/2021)

SEMINÁRIOS - Calorimetric assay to follow colorectal cancer development in experimental rat models (03/02/2021 - 03/02/2021)

SEMINÁRIOS - Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice (04/02/2021 - 04/02/2021)

SEMINÁRIOS - Low concentration of Bupivacaine ameliorates painful diabetic neuropathy by mediating miR-23a/PDE4B axis in microglia - AVALIAÇÃO E ENCERRAMENTO (05/02/2021 - 05/02/2021)